Photo Rounds

Blue-black hyperpigmentation on the extremities

Author and Disclosure Information

 

References

In addition to medication- or supple­ment-­induced hyperpigmentation, there is a physiologic source that should be considered when a patient presents with ­lower-extremity hyperpigmentation:

Stasis hyperpigmentation. Patients with chronic venous insufficiency may present with hyperpigmentation of the lower extremities. Commonly due to dysfunctional venous valves or obstruction, stasis hyperpigmentation manifests with red-brown discoloration from dermal hemosiderin deposition.4

Unlike our patient, those with stasis hyperpigmentation may present symptomatically, with associated dry skin, pruritus, induration, and inflammation. Treatment involves management of the underlying venous insufficiency.4

When there’s no obvious cause, be prepared to dig deeper

At the time of initial assessment, a thorough review of systems and detailed medication history, including over-the-counter supplements, should be obtained. Physical examination revealing diffuse, generalized hyperpigmentation with no reliable culprit medication in the patient’s history warrants further laboratory evaluation. This includes ordering renal and liver studies and tests for thyroid-stimulating hormone and ferritin and cortisol levels to rule out metabolic or endocrine hyperpigmentation disorders.

Stopping the offending medication is the first step

Discontinuation of the offending medication may result in mild improvement in skin hyperpigmentation over time. Some patients may not experience any improvement. If improvement occurs, it is important to educate patients that it can take several months to years. Dermatology guidelines favor discontinuation of antibiotics for acne or rosacea after 3 to 6 months to avoid bacterial resistance.5 Worsening hyperpigmentation despite medication discontinuation warrants further work-up.

Patients who are distressed by persistent hyperpigmentation can be treated using picosecond or Q-switched lasers.6

Our patient was advised to discontinue the minocycline. Three test spots on his face were treated with pulsed-dye laser, carbon dioxide laser, and dermabrasion. The patient noted that the spots responded better to the carbon dioxide laser and dermabrasion compared to the pulsed-dye laser. He did not ­follow up for further treatment.

Pages

Recommended Reading

Melanoma mortality rates fell in 2010s as new therapies took hold
MDedge Family Medicine
Erythrasma
MDedge Family Medicine
Teen with hyperpigmented skin lesions
MDedge Family Medicine
A 17-year-old male was referred by his pediatrician for evaluation of a year-long rash
MDedge Family Medicine
Ustekinumab matches TNF inhibitors for psoriatic arthritis in 3-year, real-world study
MDedge Family Medicine
Dupilumab significantly improves markers of AD severity in pediatric patients
MDedge Family Medicine
FDA approves Idacio as eighth adalimumab biosimilar in U.S.
MDedge Family Medicine
FDA will review pediatric indication for roflumilast cream
MDedge Family Medicine
Macules and abdominal pain
MDedge Family Medicine
Incidental skin finding
MDedge Family Medicine